RE/MAX (RMAX) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
20 Feb, 2026Executive summary
Achieved record global agent count of 148,660 as of December 31, 2025, up 1.4% year-over-year, driven by international growth despite U.S. and Canada declines.
Q4 2025 revenue was $71.1 million, down 1.8% year-over-year, with adjusted EBITDA of $22.4 million and margin of 31.5%.
Largest brokerage conversion in company history added nearly 1,200 agents in Canada, boosting market presence.
Strategic investments in brand, technology, and operational discipline supported profitability and renewed momentum.
Financial highlights
Q4 2025 revenue excluding Marketing Funds was $53.6 million, down 0.4% year-over-year.
Adjusted diluted EPS for Q4 was $0.30, flat year-over-year.
Recurring revenue streams accounted for 64.3% of revenue excluding Marketing Funds, down from 69.9% a year ago.
Adjusted free cash flow for 2025 was $31.8 million, representing 34.0% of adjusted EBITDA.
Cash and cash equivalents at year-end were $118.7 million, up $22.1 million from prior year.
Outlook and guidance
Q1 2026 guidance: agent count up 1.5%–2.5% year-over-year, revenue $69–$74 million, adjusted EBITDA $14–$17 million.
Full-year 2026 guidance: agent count up 1.5%–3.5%, revenue $285–$305 million, adjusted EBITDA $90–$100 million.
Leverage ratio expected to remain below 3.5x throughout 2026, supporting capital allocation flexibility.
Latest events from RE/MAX
- Adjusted EBITDA rose 5.4% to $28.1M despite a 4.8% revenue decline in Q2 2024.RMAX
Q2 20241 Feb 2026 - Adjusted EBITDA rose 2% to $27.3M as cost controls and global agent growth offset U.S. declines.RMAX
Q3 202417 Jan 2026 - Modest U.S. housing growth, industry adaptation, and franchise-driven cash flow support future expansion.RMAX
Stephens 26th Annual Investment Conference | NASH202413 Jan 2026 - Adjusted EBITDA rose despite revenue decline, with international agent growth offsetting U.S. losses.RMAX
Q4 202424 Dec 2025 - Annual meeting to vote on directors, pay, equity plan, and auditor, with all proposals endorsed.RMAX
Proxy Filing1 Dec 2025 - Virtual annual meeting to vote on directors, pay, incentive plan, and auditor ratification.RMAX
Proxy Filing1 Dec 2025 - Revenue fell but margins improved as global agent growth offset North America decline.RMAX
Q1 202523 Nov 2025 - Record agent count offset U.S. declines as revenue and EBITDA fell but margin improved.RMAX
Q2 202516 Nov 2025 - Q3 2025: Revenue down, margins up, record agent count, and innovation drive resilience.RMAX
Q3 20253 Nov 2025